BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27185517)

  • 21. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.
    Muñoz-López A; Romero-Moya D; Prieto C; Ramos-Mejía V; Agraz-Doblas A; Varela I; Buschbeck M; Palau A; Carvajal-Vergara X; Giorgetti A; Ford A; Lako M; Granada I; Ruiz-Xivillé N; Rodríguez-Perales S; Torres-Ruíz R; Stam RW; Fuster JL; Fraga MF; Nakanishi M; Cazzaniga G; Bardini M; Cobo I; Bayon GF; Fernandez AF; Bueno C; Menendez P
    Stem Cell Reports; 2016 Oct; 7(4):602-618. PubMed ID: 27666791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23.
    Pession A; Lo Nigro L; Montemurro L; Serravalle S; Fazzina R; Izzi G; Nucifora G; Slany R; Tonelli R
    Leukemia; 2006 Jul; 20(7):1310-3. PubMed ID: 16628191
    [No Abstract]   [Full Text] [Related]  

  • 23. MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Prange KHM; Mandoli A; Kuznetsova T; Wang SY; Sotoca AM; Marneth AE; van der Reijden BA; Stunnenberg HG; Martens JHA
    Oncogene; 2017 Jun; 36(23):3346-3356. PubMed ID: 28114278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
    Lee JH; Salci KR; Reid JC; Orlando L; Tanasijevic B; Shapovalova Z; Bhatia M
    Stem Cells; 2017 Sep; 35(9):2095-2102. PubMed ID: 28758276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Infant With Congenital Leukemia Cutis and AML-M5 With MLL Gene Rearrangement.
    Bayhan T; Çiki K; Tavil B; Gümrük F; Çetin M; Ünal Ş
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):566-7. PubMed ID: 26207776
    [No Abstract]   [Full Text] [Related]  

  • 26. Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS.
    Yang F; Cui X; Wang H; Zhang D; Luo S; Li Y; Dai Y; Yang D; Zhang X; Wang L; Zheng G; Zhang X
    Cancer Lett; 2024 Feb; 583():216652. PubMed ID: 38242196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].
    Huang S; Yang H; Gao L; Dou LP; Xu YY; Wang N; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1435-40. PubMed ID: 24370025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.
    Bergerson RJ; Collier LS; Sarver AL; Been RA; Lugthart S; Diers MD; Zuber J; Rappaport AR; Nixon MJ; Silverstein KA; Fan D; Lamblin AF; Wolff L; Kersey JH; Delwel R; Lowe SW; O'Sullivan MG; Kogan SC; Adams DJ; Largaespada DA
    Blood; 2012 May; 119(19):4512-23. PubMed ID: 22427200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Krüppel-like Factor 4 Supports the Expansion of Leukemia Stem Cells in MLL-AF9-driven Acute Myeloid Leukemia.
    Lewis AH; Bridges CS; Moorshead DN; Chen TJ; Du W; Zorman B; Sumazin P; Puppi M; Lacorazza HD
    Stem Cells; 2022 Aug; 40(8):736-750. PubMed ID: 35535819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C/EBPalpha and C/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene.
    Matsushita H; Nakajima H; Nakamura Y; Tsukamoto H; Tanaka Y; Jin G; Yabe M; Asai S; Ono R; Nosaka T; Sugita K; Morimoto A; Hayashi Y; Hotta T; Ando K; Miyachi H
    Oncogene; 2008 Dec; 27(53):6749-60. PubMed ID: 18776924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
    Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of genes psma6 and slc25a4 in patients with acute monocytic leukemia].
    Chen YX; Wang WP; Zhang PY; Zhang WG; Liu J; Ma XR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1168-73. PubMed ID: 19840444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.
    Park JW; Cho H; Oh H; Kim JY; Seo SB
    Mol Cells; 2018 May; 41(5):444-453. PubMed ID: 29477140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
    Johnson JJ; Chen W; Hudson W; Yao Q; Taylor M; Rabbitts TH; Kersey JH
    Blood; 2003 Apr; 101(8):3229-35. PubMed ID: 12515728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.
    Kim HS; Oh SH; Kim JH; Kim JY; Kim DH; Lee SJ; Choi SU; Park KM; Ryoo ZY; Park TS; Lee S
    Haematologica; 2017 Nov; 102(11):e434-e437. PubMed ID: 28798069
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
    Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
    Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PFKFB4 is critical for the survival of acute monocytic leukemia cells.
    Wang G; Li S; Xue K; Dong S
    Biochem Biophys Res Commun; 2020 Jun; 526(4):978-985. PubMed ID: 32299611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.